Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Binding and uptake of A beta1-42 by primary human astrocytes in vitro.

Glia - 1 Jul 2009

Nielsen Henrietta M, Veerhuis Robert, Holmqvist Bo, Janciauskiene Sabina

Abstract excerpt

Clearance of the amyloid-beta peptide (A beta) as a remedy for Alzheimer's disease (AD) is a major target in on-going clinical trials. In vitro studies confirmed that A beta is taken up by rodent astrocytes, but knowledge on human astrocyte-mediated A beta clearance is sparse. Therefore, by means...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to alpha 1-Antichymotrypsin
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amyloid beta-Peptides

Share to Apolipoproteins E

Share to Astrocytes

Share to Chemokine CCL2

Share to Peptide Fragments

Source

Identifiers

PMID: 19062178
DOI: 10.1002/glia.20822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19062178-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Binding and uptake of A beta1-42 by primary human astrocytes in vitro.PMID 19062178Read ↗

Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.Semantic proximity Read ↗

A neuron, microglia, and astrocyte triple coculture model to study Alzheimer diseaseSemantic proximity Read ↗

Pathological phenotypes of astrocytes in Alzheimer's disease.Semantic proximity Read ↗

Attenuating amyloid-beta pathology in mice with in situ programmed astrocytesSemantic proximity Read ↗

An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse ModelsSemantic proximity Read ↗

Expression of familial A lzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environmentSemantic proximity Read ↗

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.Semantic proximity Read ↗

Short and long TNF-alpha exposure recapitulates canonical astrogliosis events in human induced pluripotent stem cells-derived astrocytesSemantic proximity Read ↗

Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric AßSemantic proximity Read ↗

Extracellular vesicles derived from astrocyte-treated with haFGF14-154 attenuate Alzheimer phenotype in AD mice.Semantic proximity Read ↗

Astrocytic transporters in Alzheimer's diseaseSemantic proximity Read ↗

Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation stateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.